Mineralocorticoid Receptor Antagonists offer great economic value in HF patients: AHA/ACC/HFSA 2022. Dr. Prem Aggarwal28 April 2022 7:15 AM GMTMineralocorticoid Receptor Antagonists (MRA) have a great potential economic value to offer in patients with Heart Failure with mild ejection fraction ...
Spironolactone unlikely to be associated with an increased risk of cancer Hina Zahid15 March 2022 3:30 AM GMTSpironolactone, a synthetic steroid, is routinely used to manage heart failure, hypertension, and edema. Off-label, the drug is also used to treat...
MRA Strongly Recommended in Treatment of Heart Failure with Reduced Ejection Fraction: 2021 ESC Guidelines Medical Dialogues Bureau17 Nov 2021 7:15 AM GMTPharmacotherapy is the cornerstone of treatment for Heart Failure with Reduced Ejection Fraction (HFrEF) and should be implemented before considering...
Patiromer prolongs use of spironolactone independently of diabetes status: Study MD Editorial Team27 Sep 2021 3:30 AM GMTSpironolactone is recommended in patients with resistant hypertension. A new clinical trial AMBER by Dr Rajiv Agarwal, and team reported that...
Spironolactone has beneficial BP lowering effect in patients with heart failure risk Dr. Nandita Mohan12 May 2021 1:00 AM GMTAccording to recent research published in the European Heart Journal - Cardiovascular Pharmacotherapy, researchers have found out that...
Potassium being monitored in acne patients on spironolactone, defying guidelines: JAMA Medha Baranwal31 Jan 2021 8:15 AM GMTUSA: Potassium monitoring remains common in healthy young women being treated with spironolactone for acne, finds a recent study in the journal...
Oral minoxidil and spironolactone combo effective in alopecia in females: Study Medha Baranwal12 Jan 2021 12:15 AM GMTUSA: Oral minoxidil and spironolactone combo may help improving androgenetic alopecia in female adolescent patients, suggests a recent study in the...
Spironolactone effective add-on in patients with HFpEF, resistant hypertension: JAHA Medha Baranwal14 Dec 2020 11:00 PM GMTTokyo, Japan: Spironolactone may be an effective add-on medication for patients with heart failure with preserved ejection fraction (HFpEF) with...
Hair loss drug Spironolactone not tied to recurrence risk in breast cancer patients Hina Zahid14 Sep 2020 12:53 PM GMTWASHINGTON - Spironolactone is not associated with increased risk of female breast cancer recurrence, according to research from the George Washington ...
Diuretic spironolactone also reduces prostate cancer risk, finds study Medha Baranwal26 July 2020 11:00 AM GMTDelhi: The use of spironolactone may lower the risk of prostate cancer, according to a recent study. The findings of the study were presented at the...
Spironolactone safe treatment option for breast cancer therapy induced alopecia Dr. Kamal Kant Kohli29 March 2020 10:45 AM GMTSpironolactone a heart failure medication is often used off-label to treat female androgenetic hair loss because of its peripheral antiandrogen...
